A shrinkage estimator for subgroup analysis without the exchangeability assumption.

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Statistical Inference

Background:

• Shrinkage estimators enhance subgroup analyses but typically require an exchangeability assumption.
• This assumption limits their application in situations with heterogeneous treatment effects across subgroups.

Purpose of the Study:

• To develop and present a novel shrinkage estimator for exploratory subgroup analyses.
• To overcome the limitations imposed by the exchangeability assumption in existing methods.

Main Methods:

• The new estimator assumes differences between subgroup effect sizes are randomly distributed around zero, rather than exchangeability around a common mean.
• The methodology was illustrated using clinical trial data with regional variations in treatment effect size.

Main Results:

• Simulation results demonstrate that the new estimator performs comparably or better than standard shrinkage estimators.
• The estimator effectively handles scenarios where the exchangeability assumption is not met.

Conclusions:

• The proposed shrinkage estimator offers a flexible and robust alternative for subgroup analyses.
• It expands the utility of shrinkage methods in clinical research, particularly when subgroup effects vary.